Bioventus Inc.
NASDAQ: BVS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Robert Claypoole
- Employees
- 930
- Headquarters
- Durham, United States
- IPO year
- 2021
- Market cap
- $643.6M
- Website
- http://www.bioventus.com
Loading BVS…
Loading profile data…Frequently asked questions about BVS
What does Bioventus Inc. (BVS) do?
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3,...
Where does BVS trade?
Bioventus Inc. (BVS) trades on the NASDAQ.
What sector is BVS in?
Bioventus Inc. (BVS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Bioventus Inc.?
Robert Claypoole is the chief executive officer of Bioventus Inc. (BVS).
Where is Bioventus Inc. headquartered?
Bioventus Inc. is headquartered in United States.
Does BVS pay a dividend?
Bioventus Inc. (BVS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BVS go public?
Bioventus Inc. (BVS) completed its initial public offering in 2021.